论文部分内容阅读
目的评价对经皮黄疸仪检测值分组对诊治高胆红素血症的临床价值。方法对1 200例高胆红素血症足月新生儿及婴儿,依据经皮黄疸胆仪检测值的高低进行分组,经皮胆红素测定值任意部位>13mg/dl为A组125例,>10~12.9mg/dl为B组468例,7~9.9mg/dl为C组421例,5~6.9mg/dl为D组186例,根据分组分别采取不同的治疗和干预措施,A组采用光疗及综合治疗,B组采用口服茵栀黄和枯草杆菌二联活菌颗粒(妈咪爱)治疗,C组口服妈咪爱治疗,D组未给予药物治疗仅进行日光浴和口服葡萄糖水处理。结果 4组经治疗>12d后内经皮胆红素测定值降至<5mg/dl患者比例均>90%。结论经皮胆红素测定(经皮黄疸仪)值分组对诊治新生儿高胆红素血症有较高的临床实用价值。
Objective To evaluate the clinical value of subcutaneous jaundice meter in diagnosis and treatment of hyperbilirubinemia. Methods One hundred and twenty-two cases of hyperbilirubinemia full-term newborns and infants were divided into groups according to the detection value of percutaneous jaundice gallbladder, 125 cases of group A were randomized to receive any part of transcutaneous bilirubin> 13mg / dl, > 10 ~ 12.9mg / dl for the B group 468 cases, 7 ~ 9.9mg / dl for the C group of 421 cases, 5 ~ 6.9mg / dl for the D group of 186 cases, respectively, according to the group to take different treatment and intervention, Group B was treated with oral Yinzhihuang and Bacillus subtilis viability test, group C with oral Mummy treatment, and group D with no sunburn and oral glucose treatment without medication . Results After 4 days of treatment, the values of endothelium bilirubin decreased to <5 mg / dl after treatment> 12%, both> 90%. Conclusion Transcutaneous bilirubin determination (percutaneous jaundice meter) value of the diagnosis and treatment of neonatal hyperbilirubinemia has a higher clinical value.